site stats

Scpharma edgar

WebJan 4, 2024 · LEXINGTON, MA, April 26, 2024 /PRNewswire/ — scPharmaceuticals, Inc., a privately held pharmaceutical company transforming patient care and healthcare costs through innovative subcutaneous drug delivery, announced the appointment of John Tucker as president and chief executive officer, effective immediately. Mr. WebMar 31, 2024 · FREEDOM clinical study on track for topline results in Q3 2024. Ended Q1 with cash, cash equivalents, restricted cash and investments of $96.5 million. BURLINGTON, Mass., May 12, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have …

AstraZeneca-Merck

http://ir.scpharma.com/news-releases http://ir.scpharma.com/news-releases/news-release-details/scpharmaceuticals-inc-reports-first-quarter-2024-financial/ rafting in northern california https://shoptauri.com

News Releases scPharmaceuticals, Inc.

WebAbout FUROSCIX ® (furosemide injection) for subcutaneous injection . FUROSCIX is an investigational, proprietary furosemide solution formulated to a neutral pH, designed to allow for subcutaneous infusion via a wearable, pre-programmed on-body drug delivery system, for outpatient self-administration. FUROSCIX is currently under development for the … http://ir.scpharma.com/news-releases/news-release-details/scpharmaceuticals-announces-100-million-debt-financing-agreement WebMay 16, 2024 · BURLINGTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on … rafting in royal gorge

Stock To Watch: Will Second Time Be A Charm For ScPharma (SCPH)? - Nasdaq

Category:EX-99.1 - SEC

Tags:Scpharma edgar

Scpharma edgar

SEC.gov Filings & Forms - EDGAR

WebDec 7, 2024 · What Happened: Burlington, Massachusetts-based scPharma said the FDA issued a complete response letter for its new drug application for Furoscix, a proprietary, subcutaneously delivered... http://ir.scpharma.com/node/8586/html

Scpharma edgar

Did you know?

[email protected] Request Medical Information We are committed to providing current, balanced, and accurate scientific information related to scPharmaceuticals’ products. To submit a medical information request, please complete the form below and/or contact us at: 855-SCPHARMA (855-727-4272) Make a Request http://ir.scpharma.com/news-releases/news-release-details/update-scpharmaceuticals-announces-fda-approval-furoscixr

WebJul 14, 2024 · Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) WebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … EDGAR Company Filings CIK Lookup. The Central Index Key (CIK) is used on the … We would like to show you a description here but the site won’t allow us.

WebThe latest tweets from @scPharmaUSA WebFeb 15, 2024 · scPharmaceuticals Location 2400 District Ave Ste 310, Burlington, Massachusetts, 01803, United States Description Industry Drug Manufacturing & Research Pharmaceuticals Healthcare Discover more about scPharmaceuticals Dori Capretti Work Experience and Education According to ZoomInfo records, Dori Capretti’s professional …

http://ir.scpharma.com/

WebscPharmaceuticals Company Name scPharmaceuticals Main Industry Research & Development, Business Services Website www.scpharmaceuticals.com Contact Information Headquarters 2400 District Ave Ste 310, Burlington, Massachusetts, 01803, United States (617) 517-0730 scPharmaceuticals Profile and History rafting in spanishWebJan 25, 2024 · This impairment causes a domino effect in the body’s renin-angiotensin system that signals the kidneys to retain sodium and water, a condition known as congestion. Congestion can cause symptoms ranging in severity from problematic weight gain and swelling to severe fatigue and respiratory difficulties. rafting in new englandWebWHEREAS, scPharma is a biotechnology company developing biopharmaceutical drug/device products; and WHEREAS, the Parties are collaborating on the development and commercialization of certain drug/device combinations with scPharma contributing Drug-related development and Sensile contributing Device-related development. rafting in las vegasWebWELCOME TO SCSHP. South Carolina Society of Health-System Pharmacists (SCSHP) is to advance public health, safety, patient care and patient outcomes through enhancing the … rafting in south dakotaWebAt scPharmaceuticals, we are focused on exploring, developing, and commercializing innovations that will expand and advance the outpatient care of acute conditions – including worsening heart failure and bacterial infections requiring … rafting in spainWebSEC Filing scPharmaceuticals, Inc. View: Download DOC Download PDF Download XLS FWP Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Dated November 22, 2024 Relating to Preliminary Prospectus Supplement Dated November 21, 2024 Registration Statement No. 333-254637 Common stock Pre-fundedwarrants to purchase common stock rafting in south carolinaWebOct 7, 2024 · BURLINGTON, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the … rafting in stanley idaho